azathioprine has been researched along with Brain Stem Neoplasms in 1 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
Brain Stem Neoplasms: Benign and malignant intra-axial tumors of the MESENCEPHALON; PONS; or MEDULLA OBLONGATA of the BRAIN STEM. Primary and metastatic neoplasms may occur in this location. Clinical features include ATAXIA, cranial neuropathies (see CRANIAL NERVE DISEASES), NAUSEA, hemiparesis (see HEMIPLEGIA), and quadriparesis. Primary brain stem neoplasms are more frequent in children. Histologic subtypes include GLIOMA; HEMANGIOBLASTOMA; GANGLIOGLIOMA; and EPENDYMOMA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Azathioprine is used for immunosuppression in myasthenia gravis (MG)." | 7.81 | Brainstem lymphoma in a myasthenia gravis patient on azathioprine. ( Katirji, B; Termsarasab, P, 2015) |
| "Azathioprine is used for immunosuppression in myasthenia gravis (MG)." | 3.81 | Brainstem lymphoma in a myasthenia gravis patient on azathioprine. ( Katirji, B; Termsarasab, P, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Termsarasab, P | 1 |
| Katirji, B | 1 |
1 other study available for azathioprine and Brain Stem Neoplasms
| Article | Year |
|---|---|
Brainstem lymphoma in a myasthenia gravis patient on azathioprine.
Topics: Aged, 80 and over; Azathioprine; Brain Stem Neoplasms; Disease Progression; Fatal Outcome; Humans; I | 2015 |